Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-10-04
2010-12-28
Davis, Ruth A (Department: 1651)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07858579
ABSTRACT:
Neural thermoprotective compositions comprising a pharmacological inhibitor of the PKG pathway are described, as are methods of treating patients and providing neural thermoprotection with the same.
REFERENCES:
patent: 5991177 (1999-11-01), Kaczkowski
patent: 6300327 (2001-10-01), Knusel et al.
patent: 6451837 (2002-09-01), Baskys
patent: 6476007 (2002-11-01), Tao et al.
patent: 6511800 (2003-01-01), Singh
patent: 6846845 (2005-01-01), Takahashi et al.
patent: WO 93/08809 (1993-05-01), None
Canini, F., et al., “Voltametric assessment of brain nitric oxide during heatstroke in rats,”Neurosci. Lett., 1997, 231, 67-70.
Canini, F., et al., “Inhibition of different types of nitric oxide synthase: effect on thermoregulation in the rat exposed to high ambient temperature,”Neurosci. Lett., 2001, 316, 45-49.
Chang, C.P., et al., “Aminoguanidine protects against intracranial hypertension and cerebral ischemic injury in experimental heatstroke,”J. Pharmacol. Sci., 2004, 95, 56-64.
Corbin, J.D., et al., “Cyclic GMP phosphodiesterase-5: target of sildenafil.,”J. Biol. Chem., 1999, 274, 13729-13732.
Dostmann, W.R., et al., “Exploring the mechanisms of vascular smooth muscle tone with highly specific, membrane-permeable inhibitors of cyclic GMP-dependent protein kinase ialpha,”Pharmacol. Ther., 2002, 93, 203-215.
Fitzpatrick, M.J., et al., “In search of food: exploring the evolutionary link between cGMP-dependent protein kinase (PKG) and behaviour,”Integr. Comp. Biol., 2004, 44, 28-36.
Gerstberger, R., “Nitric oxide and body temperature control,”News Physiol. Sci., 1999, 14, 30-36.
Glazer, J.L., “Management of heatstroke and heat exhaustion,”American Family Physician, 2005, 11,2133-2140.
Gulec, G., et al., “Do recurrent febrile convulsions decrease the threshold for pilocarpine-induced seizures? Effects of nitric oxide,”Brain Res. Dev. Brain Res., 2001, 126, 223-228.
Gurnett, A., et al., “Purification and molecular characterization of cGMP-dependent protein kinase from apicomplexan parasites,”J. Biol. Chem., 2002, 277, 15913-15922.
Jayakar, S.S.., et al., “AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs,”Int. J. Neurosci., 2004, 114, 695-734.
Klyueva, Y.A., et al., “Role of nitric oxide and lipid peroxidation in mechanisms of febrile convulsions in Wistar rat pups,”Bull. Exp. Biol. Med., 2001, 131, 47-49.
Liu, L., et al., “Voltage-gated ion channels in nociceptors: modulation by cGMP,”J. Neurophysiol., 2004, 92, 2323-2332.
White, R.E., “Cyclic GMP and ion channel regulation,”Advances in Second Messenger and Phosphoprotein Research, 1999, 33, 251-277.
White, R.E., et al., “Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation,”Nature, 1993, 361, 263-266.
Zeng, H., et al., “The slowpoke channel binding protein slob fromdrosophila melanogasterexhibits regulatable protein kinase activity,”Neurosci. Lett., 2004, 365, 33-38.
Zhou, X.B., et al., “Protein phosphatase 2A is essential for the activation of Ca2+-- activated K+currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells,” IJ. Biol. Chem., 1996, 271, 19760-19767.
Zhou, X.B., et al., “Regulation of stably expressed and native BK channels from human myometrium by cGMP-and cAMP-dependent protein kinase,”Pflugers Arch., 1998, 436, 725-734.
Ohnishi, K., et al., “The protein kinase inhibitor, H-7, suppresses heat induced activation of head shock transcription factor 1,” Molecular and Cellular Biochemistry, 1999, 197, 129-135.
Stoop et al., “Potentiation of transmitter release by ciliary neurotrophic factor requires somatic signaling”, Science, Feb. 3, 1995, 267(5198), 695-699.
Osborne, K.A., et al., “Natural behavior polymorphism due to a cGMP-dependent protein kinase ofdrosophila,”Science, 1997, 277, 834-836.
Patel, A.L., et al., “Activation of guanosine 3',5'-cycle monophosphate (cGMP)-dependent protein kinase in rabbit aorta by nitroglycerin and sodium nitroprusside,”J. Pharmacol. Exp. Ther., 1997, 283, 885-893.
Ramirez, J.M., et al., “Long-term effects of prior heat shock on neuronal potassium currents recorded in a novel insect ganglion slice preparation,”J. Neurophysiol., 1999, 81, 795-802.
Renger, J.J., “Neuronal polymorphism among natural alleles of a cGMP-dependent kinase gene, foraging, indrosophila,” J. of Neuroscience, 1999, 19, 1-8.
Robertson, R.M., “Thermal stress and neural function: adaptive mechanisms in insect model systems,”J. of Thermal Biology, 2004, 351-358.
Sachidhanandam, S.B., et al., “Naltrexone attenuates plasma nitric oxide release following acute heat stress,”Eur. J. Pharmacol., 2002, 450, 163-167.
Werrnet, W., et al., “The cDNA of the two isoforms of bovine cGMP-dependent protein kinase,”FEBS Lett., 1989, 251(1,2), 191-196.
Schiffmann, S.N., et al., “Modulation of the voltage gated sodium current in rat striatal neurons by DARPP32, an inhibitor of protein phosphatase,”Eur. J. Neurosci., 1998, 10, 1312-1320.
Somjen, G.G., “Ion regulation in the brain;implications for pathophysiology,”Neuroscientist, 2002, 8, 254-267.
Somjen, G.G., “Mechanisms of spreading depression and hypoxic spreading depression-like depolarization,”Physiol. Rev., 81, 1065-1096, Jul. 2001.
Taylor, M.S., et al., “Inhibition of a cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation,”Mol. Pharmacol., 2004, 65, 111-1119.
Tryba, A.K., et al., “Hyperthermia modulates respiratory pacemaker bursting properties,”Neurophysiol., 2004, 92, 2844-2852.
Wang, J., et al., “Simultaneous binding of two protein kinase to a calcium-dependent potassium channel,”J. Neurosci., 1999, 19, RC4, 1-7.
Wang, J.W., et al., “A novel leg-shakingdrosophilamutant defective in a voltage-gated K+current and hypersensitive to reactive oxygen species,”J. Neurosci., 2000, 20, 5958-5964.
Armstrong Gary A.
Dawson-Scully Kenneth
Kent Clement
Robertson R. Meldrum
Sokolowski Marla
Davis Ruth A
Woodcock & Washburn LLP
LandOfFree
Thermoprotective compositions of pkg pathway inhibitors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thermoprotective compositions of pkg pathway inhibitors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thermoprotective compositions of pkg pathway inhibitors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4186651